Volume 44, Issue 1 (2026)                   jmciri 2026, 44(1): 18-30 | Back to browse issues page

Ethics code: IR.TBZMED. REC.1403.923


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hajiasgharzadeh K, Dastmalchi N, Esmalipour R. An Updated Review of Contemporary Ethical Challenges in Stem Cell Research and Therapeutic Applications. jmciri 2026; 44 (1) :18-30
URL: http://jmciri.ir/article-1-3423-en.html
Medical Philosophy and History Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Abstract:   (365 Views)
Abstract
With recent breakthroughs in regenerative medicine and the significant potential of stem cells to treat various diseases, the importance of addressing the ethical issues associated with this technology has grown rapidly. Stem cells offer promising possibilities for treating serious conditions such as neurological disorders, cardiovascular diseases, and other degenerative and autoimmune diseases. However, their application also raises complex ethical challenges that require careful examination. This review aims to explore the latest ethical issues, in the use of stem cells for research and medical treatments. Growing evidence indicates that harmonizing current laws and regulations with ethical principles, along with proposing improvements for ethical standards in stem cell research, is essential for researchers and relevant organizations. This analysis provides a recent and comprehensive overview of the ethical issues currently faced in the field of stem cell research and therapies that can assist researchers in planning ethically sound studies, thereby promoting higher quality and safer clinical outcomes.
Full-Text [PDF 461 kb]   (159 Downloads)    
Type of Study: Review |

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.